Filing Details
- Accession Number:
- 0001209191-20-042488
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-15 16:41:33
- Reporting Period:
- 2020-07-13
- Accepted Time:
- 2020-07-15 16:41:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Adm, Leg & Bd Off | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-13 | 2,125 | $90.29 | 28,963 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-13 | 100 | $284.28 | 28,863 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 225 | $285.67 | 28,638 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 100 | $286.57 | 28,538 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 200 | $288.57 | 28,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 100 | $290.65 | 28,238 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 200 | $292.76 | 28,038 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 800 | $294.57 | 27,238 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 300 | $295.38 | 26,938 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 100 | $296.48 | 26,838 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-13 | 2,125 | $0.00 | 2,125 | $90.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-07-11 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $285.67 (range $285.57 to $285.77).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $288.57 (range $288.14 to $288.99).
- Open market sales reported on this line occurred at a weighted average price of $292.76 (range $292.46 to $293.05).
- Open market sales reported on this line occurred at a weighted average price of $294.57 (range $294.15 to $295.02).
- Open market sales reported on this line occurred at a weighted average price of $295.38 (range $295.16 to $295.70).
- Fully vested.
Billionaire Hedge Funds
